» Articles » PMID: 31502166

Multiplex Immunofluorescence Assays

Overview
Specialty Molecular Biology
Date 2019 Sep 11
PMID 31502166
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Multiplexed imaging platforms to simultaneously detect multiple epitopes in the same tissue section emerged in the last years as very powerful tools to study tumor immune contexture. These revolutionary technologies are providing a deep methodology for tumor evaluation in formalin-fixed and paraffin-embedded (FFPE) to improve the understanding of tumor microenvironment, new targets for treatment, prognostic and predictive biomarkers, and translational studies. Multiplexed imaging platforms allow for the identification of several antigens simultaneously from a single tissue section, core needle biopsies, and tissue microarrays. In recent years, multiplexed imaging has improved the abilities to characterize the different types of cell populations in malignant and non-malignant tissues, and their spatial distribution in relationship to clinical outcomes. Multiplexed technologies associated with digital image analysis software offer a high-quality throughput assay to study cancer specimens at multiple time points before, during and after treatment. The aim of this chapter is to provide a review of multiplexed imaging covering its fundamentals, advantages, disadvantages, and material and methods for staining applied to FFPE tumor tissues and focusing on the use of multiplex immunofluorescence with tyramine signal amplification staining for immune profiling and translational research.

Citing Articles

Autofluorescence Virtual Staining System for H&E Histology and Multiplex Immunofluorescence Applied to Immuno-Oncology Biomarkers in Lung Cancer.

Loo J, Robbins M, McNeil C, Yoshitake T, Santori C, Shan C Cancer Res Commun. 2024; 5(1):54-65.

PMID: 39636222 PMC: 11707747. DOI: 10.1158/2767-9764.CRC-24-0327.


Application of Different Staining Methods in the Diagnosis of Pigment-Rich Melanoma.

Chengmin Z, Jiayu L, Jun H, Yang L, Zhou Y J Clin Lab Anal. 2024; 38(19-20):e25106.

PMID: 39315764 PMC: 11520935. DOI: 10.1002/jcla.25106.


Plasmonic nanoparticle sensors: current progress, challenges, and future prospects.

Kant K, Beeram R, Cao Y, Dos Santos P, Gonzalez-Cabaleiro L, Garcia-Lojo D Nanoscale Horiz. 2024; 9(12):2085-2166.

PMID: 39240539 PMC: 11378978. DOI: 10.1039/d4nh00226a.


Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.

Passaro A, Al Bakir M, Hamilton E, Diehn M, Andre F, Roy-Chowdhuri S Cell. 2024; 187(7):1617-1635.

PMID: 38552610 PMC: 7616034. DOI: 10.1016/j.cell.2024.02.041.


Optimized combination of MALDI MSI and immunofluorescence for neuroimaging of lipids within cellular microenvironments.

Shafer C, Neumann E Front Chem. 2024; 12:1334209.

PMID: 38406559 PMC: 10884125. DOI: 10.3389/fchem.2024.1334209.